PIONYR IMMUNOTHERAPEUTICS
Pionyr Immunotherapeutics is developing cancer immunotherapies that target the tumor microenvironment to enhance the body’s antitumor immunity. The company is exploiting novel target discovery and antibody generation platform technologies to create the next generation of immuno-oncology therapeutics. The company’s approach, Myeloid Tuning™, is designed to enhance the immune system’s anti-tumor response by altering the cellular infiltrate of the tumor microenvironment with high specificity.
PIONYR IMMUNOTHERAPEUTICS
Industry:
Biotechnology Medical Pharmaceutical Therapeutics
Founded:
2015-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.pionyrtx.com
Total Employee:
51+
Status:
Active
Contact:
(415)226-7503
Total Funding:
352 M USD
Technology used in webpage:
SPF Amazon AWS Global Accelerator Namefind
Similar Organizations
Alkeus Pharmaceuticals
Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions.
Carrick Therapeutics
Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Gracell Biotechnologies
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
Impulse Dynamics
Impulse Dynamics is a medical device company dedicated to offering innovative solutions for treatment of Chronic Heart Failure (CHF).
Pipeline Therapeutics
Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
RefleXion Medical
RefleXion Medical is a developer of biologically-guided radiotherapy systems for patients with cancer.
Reneo Pharmaceuticals
Reneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases.
Vedanta Biosciences
Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.
Vetsource
Vetsource provides comprehensive solutions to those who care for pets - veterinarians and pet owners.
Current Advisors List
Board_member
Board_member
2005-01-01
Board_member
Board_member
Board_observer
Current Employees Featured
Venkataraman Sriram VP of ImmunoPharmacology & Early Development @ Pionyr Immunotherapeutics
VP of ImmunoPharmacology & Early Development
Leonard Reyno Senior Vice President and Chief Medical Officer @ Pionyr Immunotherapeutics
Senior Vice President and Chief Medical Officer
Steve James CEO @ Pionyr Immunotherapeutics
CEO
Sachdev Sidhu Founder @ Pionyr Immunotherapeutics
Founder
Alicia Levey CBO and SVP @ Pionyr Immunotherapeutics
CBO and SVP
Kevin P. Baker SVP of Preclinical Sciences and Program Management @ Pionyr Immunotherapeutics
SVP of Preclinical Sciences and Program Management
Michel Streuli Senior Vice President and Chief Scientific Officer @ Pionyr Immunotherapeutics
Senior Vice President and Chief Scientific Officer
Monte Montgomery Senior Vice President and Chief Financial Officer @ Pionyr Immunotherapeutics
Senior Vice President and Chief Financial Officer
Lisa Stemmerich VP of Human Resources @ Pionyr Immunotherapeutics
VP of Human Resources
Max Krummel Founder @ Pionyr Immunotherapeutics
Founder
Founder
Investors List
Gilead Sciences
Gilead Sciences investment in Corporate Round - Pionyr Immunotherapeutics
JLABS
JLABS investment in Series B - Pionyr Immunotherapeutics
SV Health Investors
SV Health Investors investment in Series B - Pionyr Immunotherapeutics
Stephen Hoffman
Stephen Hoffman investment in Series B - Pionyr Immunotherapeutics
Vida Ventures
Vida Ventures investment in Series B - Pionyr Immunotherapeutics
OrbiMed
OrbiMed investment in Series B - Pionyr Immunotherapeutics
Mission Bay Capital
Mission Bay Capital investment in Series B - Pionyr Immunotherapeutics
QB3
QB3 investment in Series B - Pionyr Immunotherapeutics
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series B - Pionyr Immunotherapeutics
Sofinnova Investments
Sofinnova Investments investment in Series B - Pionyr Immunotherapeutics
Official Site Inspections
http://www.pionyrtx.com
- Host name: ewhserver1302.edgewebhosting.net
- IP address: 69.63.140.80
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Pionyr Immunotherapeutics"
Pionyr Immunotherapeutics - LinkedIn
Pionyr Immunotherapeutics | 4,993 followers on LinkedIn. The New Frontier of Immuno-Oncology | In 2015, Pionyr Immunotherapeutics embarked on a journey to forge a new path in immuno …See details»
Pionyr Immunotherapeutics - Crunchbase Company Profile
Contact Email info@pionyrtx.com; Phone Number (415)226-7503; Pionyr Immunotherapeutics is developing cancer immunotherapies that target the tumor microenvironment to enhance the …See details»
Pionyr Immunotherapeutics - Overview, News & Similar
Mar 1, 2023 View Pionyr Immunotherapeutics (www.pionyrtx.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Gilead Sciences Secures Exclusive Option to Acquire Pionyr ...
Jun 23, 2020 For more information, please visit www.pionyrtx.com. About Gilead Sciences. Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, …See details»
Pionyr Immunotherapeutics - PitchBook
Information on acquisition, funding, cap tables, investors, and executives for Pionyr Immunotherapeutics. Use the PitchBook Platform to explore the full profile.See details»
Pionyr Immuntherapeutics - 2025 Company Profile - Tracxn
Mar 28, 2025 Pionyr Immuntherapeutics - Cancer immunotherapies that target the tumour microenvironment to enhance the body’s antitumour immunity. Acquired by Ikena Oncology. …See details»
Pionyr Immunotherapeutics - Craft
Pionyr Immunotherapeutics has 5 employees at their 1 location and $345 m in total funding,. See insights on Pionyr Immunotherapeutics including office locations, competitors, revenue, …See details»
Pionyr - VentureRadar
Pionyr is exploiting novel target discovery and antibody generation platform technologies to create the next generation of immuno-oncology... ... Find out more about ...See details»
Pionyr Immunotherapeutics - Wiki - Golden
Pionyr Immunotherapeutics is a San Francisco-based biotechnology company and developer of cancer immunotherapies designed to target the tumor microenvironment.See details»
Pionyr Immunotherapeutics Overview | SignalHire Company Profile
Pionyr Immunotherapeutics is a private company that has been in the industry for 9 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the President & CEO is occupied by Steven P JamesSee details»
Pionyr Immunotherapeutics Company Profile | Management and
Smith@pionyrtx.com: Pionyr Immunotherapeutics Top Competitors. Company Employees Revenue Top technologies; Zumutor Biologics Inc. 25: $5.3 M: Abveris Inc. 13: $3.8 M: ExonBIO. 17: $4.7 M: Abzyme Therapeutics LLC. 8: $4.3 M: TetraGenetics Inc. 13: $2.4 M: Your Questions, Our Answers Get Free Access to Pionyr Immunotherapeutics Contacts Info.See details»
Pionyr Immunotherapeutics Inc in South San Francisco, CA - (415) …
Pionyr Immunotherapeutics Inc is in the Pharmaceutical Preparations business. View competitors, revenue, employees, website and phone number.See details»
pionyrtx.com - Pionyr Immunotherapeutics | Ca... - Pionyr Tx - Sur.ly
Pionyrtx.com. Pionyr Immunotherapeutics is a clinical stage company developing cancer immunotherapies that target the tumor microenvironment to ...See details»
Pionyr Immunotherapeutics Company Overview, Contact Details ...
Jun 23, 2020 Ikena Oncology, Inc. acquired Pionyrtx on Aug 7th '23. ... 8733 - Noncommercial Research Organizations. NAICS Code 541714 - Research and Development in Biotechnology …See details»
Pionyr Immunotherapeutics - F6S
In 2015, Pionyr Immunotherapeutics embarked on a journey to forge a new path in immuno-oncology for patients in need. We are a clinical stage company discovering and developing …See details»
PIONYR Immunotherapeutics Announces Key Leadership Team …
SOUTH SAN FRANCISCO, Aug. 27, 2019 /PRNewswire/ -- PIONYR Immunotherapeutics, Inc., a company developing antibody therapeutics that increase the body's antitumor immunity by …See details»
Nextsource | Company Profile | Pionyr Immunotherapeutics
Explore the company profile of Pionyr Immunotherapeutics (pionyrtx.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Pionyr Immunotherapeutics’ Post - LinkedIn
Check out our new and improved website, all about #myeloidtuning and the mechanism of actions for our two lead programs that have been cleared to begin…See details»
Pionyr Immunotherapeutics CEO and Key Executive Team
Pionyr Immunotherapeutics's Senior Vice President and Chief Development Officer is Kevin Baker. Other executives include Leonard Reyno, Executive Vice President and Chief Medical Officer; Carol Gallagher, Director and 17 others. See the full leadership team at Craft.See details»
Working at Pionyr Immunotherapeutics - Zippia
Www.pionyrtx.com. Organization Type. Private. CEO. Steven P. James. Social Media. Pionyr Immunotherapeutics is developing cancer immunotherapies that target the tumor …See details»